Načítá se...
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin
We hypothesize that the efficacy of doxorubicin can be maximized and dose-limiting cardiotoxicity minimized by controlled release from PEGylated nanoparticles. To test this hypothesis, a unique surface modification technique was used to create PEGylated PLGA nanoparticles encapsulating doxorubicin....
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2789916/ https://ncbi.nlm.nih.gov/pubmed/19341815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2009.02.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|